Companies: 10,795·Total market cap: $144.5T
Everus Construction Group, Inc.

Everus Construction Group, Inc.

ECGNYSEIndustrials● Active
$151.12
+$0.83(+0.55%)
Market Cap$7.7B
P/E Ratio
52W High$171.577
52W Low$58

Everus Construction Group, Inc. (ECG) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

ecg · stock forecast · 6 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 6 Wall Street analysts in the past 3 months

SellBuy

Buy

6 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
4
Hold
2
Sell
0
Strong Sell
0
Total: 6 · Buy rate: 66.7%

12-Month Price Target

High

$180

Consensus

$154

+1.7% upside

Low

$115

Median: $160 · Last Close: $151.06

The Everus Construction Group, Inc. (ECG) analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month ECG price target is $153.60, representing +1.7% upside from the current price of $151.06.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $154 (1.7%)

Consensus Target

$153.60

1.7% upside

High Target

$180

19.2%

Low Target

$115

-23.9%

Current Price

$151.06

as of today

Based on analyst price targets, the ECG stock price prediction for the next 12 months ranges from $115 to $180. The consensus ECG price forecast of $153.60 implies 1.7% upside from the current price of $151.06.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$150.250.53%

1-day model range: $149.25–$151.26. Peak: $151.26 (-0.53%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$272+80.0%
2028$402+166.4%
2029$518+243.1%
2030$608+302.4%
2031+344.1%
Confidence:MediumCapped at 80% annual limit

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

64%7%29%
9Buy
1Neutral
4Sell
RSI (14)54.0Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · ECG · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$151.77SELL
MA 10$150.71BUY
MA 20$152.59SELL
MA 50$142.17BUY
MA 100$123.72BUY
MA 200$105.04BUY
Current $ECG · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$151.19SELL
EMA 10$151.12SELL
EMA 20$150.52BUY
EMA 50$142.19BUY
EMA 100$128.43BUY
EMA 200$110.24BUY
Current $ECG · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Cantor Fitzgerald2026-05-11
Maintains
NeutralNeutral
Oppenheimer2026-05-07
Maintains
OutperformOutperform
Guggenheim2026-04-30
Upgrade ↑
NeutralBuy
Stifel2026-04-15
Maintains
BuyBuy
Freedom Broker2026-02-26
Maintains
BuyBuy
Cantor Fitzgerald2026-02-26
Maintains
NeutralNeutral
DA Davidson2026-02-26
Maintains
NeutralNeutral
DA Davidson2026-02-25
Maintains
NeutralNeutral
Stifel2026-01-26
Maintains
BuyBuy
Stifel2025-10-09
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Everus Construction Group, Inc. (ECG) stock. Of the recent 21 rating actions, 1 were upgrades and 0 were downgrades. 6 analysts currently cover ECG.

Analyst Recommendation Trends

Buy ratings11
Hold ratings01↑ +1
Sell ratings00

ECG analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$4.4B

↓ 15.8% YoY

Revenue Next Year

$4.8B

↑ 10.4% YoY

EPS This Year

$4.53

EPS Next Year

$5.04

↑ 11.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ECG EPS of $4.53 for the current fiscal year, based on estimates from 4 analysts. The ECG revenue forecast is $4.4B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The ECG stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ECG price target is $153.60 (+1.7% upside), with an analyst consensus of Buy.

The ECG short-term stock prediction for tomorrow is $150.25 (-0.53%). The ECG stock price prediction for 2027 estimates an average of $272. The ECG stock prediction for 2030 projects a range of $563–$652.

Everus Construction Group, Inc. trades on NYSE under the ticker ECG. The ECG stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

ECG forecast · 8 questions

According to 6 Wall Street analysts, the average 12-month ECG price target is $153.60, with a high forecast of $180.00 and a low of $115.00. The median price target is shown in the chart above when available. This implies +1.7% potential upside from the current price of $151.06.

ECG price targetWhat is ECG price targetECG analyst price targetECG 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.